Joseph Vazzano's Insider Trades & SAST Disclosures
Joseph Vazzano's most recent trade in Allarity Therapeutics Inc was a trade of 25,000 Stock Options done . Disclosure was reported to the exchange on Jan. 22, 2025.
Add Superstar Alert
Note
This is a custom search result for pattern Joseph Vazzano.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
Allarity Therapeutics Inc
|
Joseph W. Vazzano | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2025 | 25,000 | 25,000 | - | - | Stock Options | |
|
Abeona Therapeutics Inc
Board Meeting |
Joseph W. Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 144,509 | 509,726 (0%) | 0% | 0 | Common stock | |
|
Abeona Therapeutics Inc
Board Meeting |
Joseph W. Vazzano | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.89 per share. | 28 Sep 2024 | 6,388 | 365,217 (0%) | 0% | 5.9 | 37,625 | Common stock |
|
Abeona Therapeutics Inc
Board Meeting |
Joseph W. Vazzano | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.11 per share. | 21 Jul 2024 | 1,055 | 371,605 (0%) | 0% | 5.1 | 5,391 | Common stock |
|
Abeona Therapeutics Inc
Board Meeting |
Joseph W. Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 155,200 | 372,660 (0%) | 0% | 0 | Common stock | |
|
Abeona Therapeutics Inc
Board Meeting |
Joseph Vazzano | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.52 per share. | 05 Jun 2024 | 16,408 | 217,460 (0%) | 0% | 4.5 | 74,164 | Common stock |
|
Abeona Therapeutics Inc
Board Meeting |
Joseph Vazzano | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.14 per share. | 25 Apr 2024 | 5,608 | 233,868 (0%) | 0% | 3.1 | 17,609 | Common stock |
|
Abeona Therapeutics Inc
Board Meeting |
Joseph Vazzano | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.14 per share. | 15 Mar 2024 | 703 | 228,260 (0%) | 0% | 8.1 | 5,722 | Common stock |
|
Abeona Therapeutics Inc
Board Meeting |
Joseph Vazzano | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.73 per share. | 24 Jul 2023 | 1,187 | 235,179 (0%) | 0% | 3.7 | 4,428 | Common stock |
|
Abeona Therapeutics Inc
Board Meeting |
Joseph Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 141,908 | 236,366 (0%) | 0% | 0 | Common stock | |
|
Abeona Therapeutics Inc
Board Meeting |
Joseph Vazzano | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.60 per share. | 15 Mar 2023 | 792 | 94,458 (0%) | 0% | 2.6 | 2,059 | Common stock |
|
Abeona Therapeutics Inc
Board Meeting |
Joseph Vazzano | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 4.00 per share. | 18 Nov 2022 | 2,500 | 95,250 (0%) | 0% | 4 | 10,000 | Common stock |
|
Abeona Therapeutics Inc
Board Meeting |
Joseph Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Sep 2022 | 72,750 | 92,750 (0%) | 0% | 0 | Common stock | |
|
Abeona Therapeutics Inc
Board Meeting |
Joseph Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jul 2022 | 12,000 | 20,000 (0%) | 0% | 0 | Common stock | |
|
Abeona Therapeutics Inc
Board Meeting |
Joseph Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 200,000 | 200,000 (0%) | 0% | 0 | Common stock | |
|
Avenue Therapeutics Inc
Board Meeting |
Joseph Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Dec 2021 | 100,505 | 165,757 (0%) | 0% | 0 | Common Stock | |
|
Avenue Therapeutics Inc
Board Meeting |
Joseph Vazzano | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.62 per share. | 15 Sep 2021 | 7,160 | 65,252 (0%) | 0% | 1.6 | 11,599 | Common Stock |
|
Avenue Therapeutics Inc
Board Meeting |
Joseph Vazzano | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.13 per share. | 20 Aug 2020 | 3,840 | 57,412 (0%) | 0% | 12.1 | 46,579 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges